p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment

Eur J Cancer. 1996 Nov;32A(12):2182-3. doi: 10.1016/s0959-8049(96)00222-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / metabolism*
  • Female
  • Humans
  • Neoplasm Proteins / metabolism
  • Survival Rate
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Biomarkers, Tumor
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Neoplasm Proteins
  • Tumor Suppressor Protein p53